All updated as on -
From 2024 to 2031, the worldwide demand for intra aortic balloon pumps is projected to grow at a CAGR of 15.3%, from 455.49 million USD in 2023 to almost 1025.84 million USD in 2031.
When the heart is unable to pump enough blood to the body's parts, a therapeutic device called an intra-aortic balloon pump (IABP) can help. A catheter—a thin, flexible tube—makes up the pump. An intraatrial balloon pump (IABP) is a thin, long tube that controls blood pressure in the aorta, the body's primary blood artery. A temporary support system for the left ventricle, the intra-aortic balloon pump (IABP) uses counterpulsation to inflate and deflate an intra-aortic balloon. Intensive ambulatory blood pressure monitoring (IABP) is effective in treating cardiogenic shock. In addition to reopening or bypassing a blocked artery close to the heart, an IABP may help the patient recuperate after surgery.
An example of a therapeutic device is the intra-aortic balloon pump, which helps the patient's heart pump enough blood. When a person's heart cannot pump enough blood to meet their body's needs, an intra-aortic balloon pump (IABP) is used. Cardiogenic shock, in which the heart fails to pump enough blood to satisfy the body's demands, is treated with the intra-aortic balloon pump (IABP) technique. An intra-aortic balloon pump (IABP) mainly helps improve blood flow into the coronary arteries. Patients undergoing surgery to reopen or bypass clogged arteries close to the heart often benefit from the use of an intra-aortic balloon pump (IABP). Unstable angina, myocardial infarction, and chronic heart failure are the main indications for the use of intra aortic balloon pumps.
Improving blood flow to and from the heart is the primary advantage of using an intra aortic balloon pump (IABP). Additionally, it lessens the workload on the heart. For this reason, the intra aortic balloon pump (IABP) is the gold standard for treating CAD. One reason intra aortic balloon pumps (IABP) are becoming more popular is because coronary artery disease (CAD) is becoming more common.
We are recalling the intra-aortic balloon pump product range due to prominent reasons such as worries about fluid leakage, distorted packaging, government interference, and non-sterility, among others. Consider the recall of Rescue IABPs and Cardiosave Hybrid IABPs, two models of intra-aortic balloon pumps, that occurred in December 2023 at Datascope, a subsidiary of Getinge. The intra aortic balloon pump was mostly recalled because of a problem with leakage. The blood entering the intra aortic balloon pump can be affected by balloon leaking.
Coronary artery diseases and chronic heart failure make up the indication segment. Market share for intra aortic balloon pumps was most in the coronary artery diseases category in 2023. Intra aortic balloon pumps (IABPs) are characterized by a number of important characteristics, such as superior clinical support, simplicity and economy in design and engineering, and horizontal ports that are easy to attach. Because of these notable characteristics, the intra aortic balloon pump can maintain a steady rate of blood flow to the heart. So, for patients with coronary artery conditions such unstable angina and myocardial infarction, intra aortic balloon pumps guarantee accuracy in time.
For example, 1 out of 4 individuals on Earth will reportedly experience a stroke at some point in their lives, and the risks of developing stroke (myocardial infarction) have increased by 50% in the past 17 years, according to the World Health Organization's (WHO) 2023 Global Stroke Factsheet. Therefore, the need for intra aortic balloon pumps (IABPs) to raise diastolic aortic pressure and enhance blood flow is being propelled by the increasing prevalence of coronary artery disorders, which is subsequently fueling the market's acceleration.
Report Coverage
Global Intra Aortic Balloon Pumps research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Intra Aortic Balloon Pumps report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Intra Aortic Balloon Pumps competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Intra Aortic Balloon Pumps market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Intra Aortic Balloon Pumps market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Intra Aortic Balloon Pumps market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Teleflex Incorporated. (U.S.), MAQUET Holding B.V. & Co. KG. (Germany), Zeon Corporation (Japan), Tokai Medical Products, Inc. (Japan), SENKO MEDICAL INSTRUMENT Mfg. CO., Ltd. (Japan), InterValve Medical Inc. (U.S.), Insightra Medical, Inc. LLC (U.S.), Getinge AB (Sweden), Terumo Medical Corporation (Japan), W. L. Gore & Associates, Inc. (U.S.), Lepumedical.com (China), Medtronic (Ireland), Abbott (U.S.), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Berlin Heart (Germany), CardiacAssist, Inc. (U.S.), and ReliantHeart Inc. (U.S.) among others
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Intra Aortic Balloon Pumps market based on the below-mentioned segments:
Global Intra Aortic Balloon Pumps Market, By Type
Intra – Aortic Balloon Pump (Iabp) Console
Intra – Aortic Balloon Pump (Iabp) Catheters
Introducer Tray
Global Intra Aortic Balloon Pumps market, By Indication
Coronary Artery Diseases
Unstable Angina
Myocardial Infarction (NSTEMI)
Chronic Heart Failure
Global Intra Aortic Balloon Pumps Market, By End User
Hospitals
Ambulatory Surgical Centres
Independent Catherization Labs
Global Intra Aortic Balloon Pumps market, Regional Analysis
When the heart is unable to pump enough blood to the body's parts, a therapeutic device called an intra-aortic balloon pump (IABP) can help. A catheter—a thin, flexible tube—makes up the pump. An intraatrial balloon pump (IABP) is a thin, long tube that controls blood pressure in the aorta, the body's primary blood artery. A temporary support system for the left ventricle, the intra-aortic balloon pump (IABP) uses counterpulsation to inflate and deflate an intra-aortic balloon. Intensive ambulatory blood pressure monitoring (IABP) is effective in treating cardiogenic shock. In addition to reopening or bypassing a blocked artery close to the heart, an IABP may help the patient recuperate after surgery.
An example of a therapeutic device is the intra-aortic balloon pump, which helps the patient's heart pump enough blood. When a person's heart cannot pump enough blood to meet their body's needs, an intra-aortic balloon pump (IABP) is used. Cardiogenic shock, in which the heart fails to pump enough blood to satisfy the body's demands, is treated with the intra-aortic balloon pump (IABP) technique. An intra-aortic balloon pump (IABP) mainly helps improve blood flow into the coronary arteries. Patients undergoing surgery to reopen or bypass clogged arteries close to the heart often benefit from the use of an intra-aortic balloon pump (IABP). Unstable angina, myocardial infarction, and chronic heart failure are the main indications for the use of intra aortic balloon pumps.
Improving blood flow to and from the heart is the primary advantage of using an intra aortic balloon pump (IABP). Additionally, it lessens the workload on the heart. For this reason, the intra aortic balloon pump (IABP) is the gold standard for treating CAD. One reason intra aortic balloon pumps (IABP) are becoming more popular is because coronary artery disease (CAD) is becoming more common.
We are recalling the intra-aortic balloon pump product range due to prominent reasons such as worries about fluid leakage, distorted packaging, government interference, and non-sterility, among others. Consider the recall of Rescue IABPs and Cardiosave Hybrid IABPs, two models of intra-aortic balloon pumps, that occurred in December 2023 at Datascope, a subsidiary of Getinge. The intra aortic balloon pump was mostly recalled because of a problem with leakage. The blood entering the intra aortic balloon pump can be affected by balloon leaking.
Coronary artery diseases and chronic heart failure make up the indication segment. Market share for intra aortic balloon pumps was most in the coronary artery diseases category in 2023. Intra aortic balloon pumps (IABPs) are characterized by a number of important characteristics, such as superior clinical support, simplicity and economy in design and engineering, and horizontal ports that are easy to attach. Because of these notable characteristics, the intra aortic balloon pump can maintain a steady rate of blood flow to the heart. So, for patients with coronary artery conditions such unstable angina and myocardial infarction, intra aortic balloon pumps guarantee accuracy in time.
For example, 1 out of 4 individuals on Earth will reportedly experience a stroke at some point in their lives, and the risks of developing stroke (myocardial infarction) have increased by 50% in the past 17 years, according to the World Health Organization's (WHO) 2023 Global Stroke Factsheet. Therefore, the need for intra aortic balloon pumps (IABPs) to raise diastolic aortic pressure and enhance blood flow is being propelled by the increasing prevalence of coronary artery disorders, which is subsequently fueling the market's acceleration.
Report Coverage
Global Intra Aortic Balloon Pumps research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Intra Aortic Balloon Pumps report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Intra Aortic Balloon Pumps competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Intra Aortic Balloon Pumps market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Teleflex Incorporated. (U.S.), MAQUET Holding B.V. & Co. KG. (Germany), Zeon Corporation (Japan), Tokai Medical Products, Inc. (Japan), SENKO MEDICAL INSTRUMENT Mfg. CO., Ltd. (Japan), InterValve Medical Inc. (U.S.), Insightra Medical, Inc. LLC (U.S.), Getinge AB (Sweden), Terumo Medical Corporation (Japan), W. L. Gore & Associates, Inc. (U.S.), Lepumedical.com (China), Medtronic (Ireland), Abbott (U.S.), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Berlin Heart (Germany), CardiacAssist, Inc. (U.S.), and ReliantHeart Inc. (U.S.) among others |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Intra Aortic Balloon Pumps Market from 2021 to 2031.
- Market Forecast for Intra Aortic Balloon Pumps Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Intra Aortic Balloon Pumps competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Intra Aortic Balloon Pumps
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Intra Aortic Balloon Pumps market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Intra Aortic Balloon Pumps market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Teleflex Incorporated. (U.S.), MAQUET Holding B.V. & Co. KG. (Germany), Zeon Corporation (Japan), Tokai Medical Products, Inc. (Japan), SENKO MEDICAL INSTRUMENT Mfg. CO., Ltd. (Japan), InterValve Medical Inc. (U.S.), Insightra Medical, Inc. LLC (U.S.), Getinge AB (Sweden), Terumo Medical Corporation (Japan), W. L. Gore & Associates, Inc. (U.S.), Lepumedical.com (China), Medtronic (Ireland), Abbott (U.S.), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Berlin Heart (Germany), CardiacAssist, Inc. (U.S.), and ReliantHeart Inc. (U.S.) among others
Primary Target Market
- Market Players of Intra Aortic Balloon Pumps
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Intra Aortic Balloon Pumps market based on the below-mentioned segments:
Global Intra Aortic Balloon Pumps Market, By Type
Intra – Aortic Balloon Pump (Iabp) Console
Intra – Aortic Balloon Pump (Iabp) Catheters
Introducer Tray
Global Intra Aortic Balloon Pumps market, By Indication
Coronary Artery Diseases
Unstable Angina
Myocardial Infarction (NSTEMI)
Chronic Heart Failure
Global Intra Aortic Balloon Pumps Market, By End User
Hospitals
Ambulatory Surgical Centres
Independent Catherization Labs
Global Intra Aortic Balloon Pumps market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive intra aortic balloon pumps market market research and competitor analysis for your business to help you develop more profound insights into the intra aortic balloon pumps market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the intra aortic balloon pumps market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.